21 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
committee has assessed the independence of Pearl Meyer consistent with Nasdaq listing standards and has concluded that the engagement does not raise any … responsibilities.
The nominating and corporate governance committee may also consider factors such as judgment, diversity, independence, skills, education
8-K
a75cy9tlchr
14 Jul 21
Departure of Directors or Certain Officers
8:19am
8-K
qppj9rarj8292kofznjv
26 Apr 21
Departure of Directors or Certain Officers
8:05am
8-K
xqsctez51iv7c lrd
10 Jun 20
Departure of Directors or Certain Officers
8:36am
DEF 14A
m73y080isimnd72lh
27 Apr 20
Definitive proxy
7:30am
10-K
EX-10.12
i1bu pxby8oyrl6s
16 Mar 20
Annual report
5:17pm
10-K
d527rdahgr9rvv
16 Mar 20
Annual report
5:17pm
8-K
xevlole942lhb
6 Sep 19
Departure of Directors or Certain Officers
4:34pm
424B4
9xx91rhyodua8dccv3
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
tap5in1phhxi5rvzd
10 Jun 19
IPO registration (amended)
11:16am
S-1
2imikltbs15a8r00
24 May 19
IPO registration
4:18pm
DRS/A
i5nypcuxjd95cdeyiw
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
s16 jftmhl171u
19 Mar 19
Draft registration statement (amended)
12:00am